Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Amines & Plasticizers Ltd

AMNPLST
NSE
166.92
0.74%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Amines & Plasticizers Ltd

AMNPLST
NSE
166.92
0.74%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
918Cr
Close
Close Price
166.92
Industry
Industry
Speciality Chemicals
PE
Price To Earnings
25.41
PS
Price To Sales
1.46
Revenue
Revenue
630Cr
Rev Gr TTM
Revenue Growth TTM
-4.07%
PAT Gr TTM
PAT Growth TTM
-12.34%
Peer Comparison
How does AMNPLST stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
AMNPLST
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Revenue
RevenueCr
161167137157175177137167191166140133
Growth YoY
Revenue Growth YoY%
12.69.2-1.019.89.16.30.35.98.8-6.52.0-20.1
Expenses
ExpensesCr
151153123141158155123150174145127122
Operating Profit
Operating ProfitCr
91414161722151617211311
OPM
OPM%
5.78.310.310.19.712.410.89.88.912.79.38.1
Other Income
Other IncomeCr
110110000000
Interest Expense
Interest ExpenseCr
233433223321
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
6111112131712131317108
Tax
TaxCr
233345333432
PAT
PATCr
59891013910101376
Growth YoY
PAT Growth YoY%
36.753.839.2151.8100.851.49.37.6-1.2-1.0-14.2-36.9
NPM
NPM%
3.15.15.85.85.67.36.35.95.17.75.34.6
EPS
EPS
0.91.61.41.61.82.41.61.81.82.31.41.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
302262295326455399442563597647661630
Growth
Revenue Growth%
23.7-13.112.510.739.4-12.310.727.46.18.32.1-4.7
Expenses
ExpensesCr
280239267298421357389523555578592568
Operating Profit
Operating ProfitCr
222328283442534042696962
OPM
OPM%
7.38.99.68.77.410.411.97.17.110.710.49.8
Other Income
Other IncomeCr
001431553311
Interest Expense
Interest ExpenseCr
10867891091013108
Depreciation
DepreciationCr
222333445566
PBT
PBTCr
101421232630443230545549
Tax
TaxCr
4568961187141412
PAT
PATCr
6915151625332423404136
Growth
PAT Growth%
89.644.163.6-0.311.349.732.5-26.8-4.174.13.0-11.8
NPM
NPM%
2.13.55.04.53.66.27.44.23.86.26.25.7
EPS
EPS
1.11.62.72.73.04.55.94.34.27.27.56.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
61111111111111111111111
Reserves
ReservesCr
283044577197130151172209248258
Current Liabilities
Current LiabilitiesCr
7872799213088130115131139138100
Non Current Liabilities
Non Current LiabilitiesCr
272627304035343331312021
Total Liabilities
Total LiabilitiesCr
138140161190252232305310344389416390
Current Assets
Current AssetsCr
9091106128174149217220256303332308
Non Current Assets
Non Current AssetsCr
484855627883889088868482
Total Assets
Total AssetsCr
138140161190252232305310344389416390

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
7141022103144-2754729
Investing Cash Flow
Investing Cash FlowCr
-3-1-5-4-16-17-6-4-2-1-3
Financing Cash Flow
Financing Cash FlowCr
-3-13-5-1412-226-130-16-20
Net Cash Flow
Net Cash FlowCr
0-1046-844-433306
Free Cash Flow
Free Cash FlowCr
3124141433-3524326
CFO To PAT
CFO To PAT%
103.7149.964.2146.559.2125.5133.5-111.319.8117.671.1
CFO To EBITDA
CFO To EBITDA%
29.358.333.576.128.774.082.4-66.110.767.842.2

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
84922193181831104206013859091,179
Price To Earnings
Price To Earnings
13.610.414.821.611.14.512.925.216.822.828.8
Price To Sales
Price To Sales
0.30.30.71.00.40.30.91.10.61.41.8
Price To Book
Price To Book
2.62.34.04.72.21.03.03.72.14.14.6
EV To EBITDA
EV To EBITDA
6.46.39.712.87.23.98.416.610.813.817.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
27.732.334.831.628.233.035.828.428.131.932.4
OPM
OPM%
7.38.99.68.77.410.411.97.17.110.710.4
NPM
NPM%
2.13.55.04.53.66.27.44.23.86.26.2
ROCE
ROCE%
21.821.924.024.721.424.425.017.515.121.919.3
ROE
ROE%
18.922.226.721.720.122.823.214.712.518.115.8
ROA
ROA%
4.56.59.27.86.510.610.77.76.710.29.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Amines & Plasticizers Limited (APL), established in **1973** and headquartered in **Mumbai, India**, is a premier manufacturer of specialty amines, alkanolamines, morpholine derivatives, gas-treating solvents, and EO/PO-based specialty chemicals. The company operates two integrated manufacturing facilities across Maharashtra and serves a global clientele in over **85 countries**, including North America, Europe, the Middle East, and Asia. APL is recognized as a leader in high-barrier specialty chemicals, driven by innovation, technical expertise, and sustainability. --- ### **Core Business Segments & Product Portfolio** APL’s product range is strategically aligned across several high-growth industrial sectors: #### **1. Gas Treating Chemicals & Specialty Solvents (45.14% of FY25 Revenue)** - Key products: **Methyldiethanolamine (MDEA)**, **Aminosol® Series**, Actisol, Aminosol FGS, Aminosol HST. - Applications: CO₂ and H₂S removal in refineries, fertilizer plants, natural gas processing, ammonia units, and biogas systems. - APL was the **first Indian company to indigenously develop MDEA**, now a benchmark solvent globally. - Offers **custom-formulated solvents** for carbon capture technologies, including partnerships with a leading Japanese MNC. - Provides **on-site amine reclamation and purification services** via mobile and stationary units to manage heat-stable salt (HSS) buildup. #### **2. Alkanolamines & Alkyl Alkanolamines (31.77% of FY25 Revenue)** - Products: Methyl Monoethanolamine, Tertiary Butyl diethanolamine, N-Benzyl ethanolamine, Dibutylethanolamine. - Uses: Surfactants, polymers, water treatment, cleaning agents, pharmaceuticals, and agrochemicals. - Supplies **~70–80% of India’s domestic demand** for ethanolamines and alkyl alkanolamines. #### **3. Morpholine Derivatives (11.14% of FY25 Revenue)** - Flagship product: **N-Methyl Morpholine Oxide (NMMO)** — APL ranks among the **world’s top three producers**, with **#1 capacity globally**. - NMMO is a key solvent in **eco-friendly Lyocell/viscose fiber production**, replacing polluting viscose processes. - Other derivatives: N-Methyl, N-Ethyl, N-Acetyl, N-Formyl morpholines — used in pharmaceuticals, crop protection, and textiles. - REACH-registered (TII) for export compliance to Europe. #### **4. EO/PO-Based Derivatives (10.36% of FY25 Revenue)** - Products: Alcohol ethoxylates (TAPE, APSURF), glycerol polyol, phenoxyethanol (high purity), triisopropanolamine, DEIPA, PPGs. - Applications: Surfactants, polyurethane, personal care, cosmetics, drug intermediates, electronic chemicals, and green formulations. - R&D focus on **tridecyl alcohol ethoxylate surfactants** for high-purity markets. #### **5. Oilfield Chemicals & “Others” Segment (1.59% of FY25 Revenue)** - Portfolio includes: - **H₂S scavengers**: Aminosol HSTIP, AMINOCIDE BK 50. - **Demulsifiers & corrosion inhibitors**: AMINO PPD C/L Series. - **Molecular sieves** for purification. - Also offers **dissolved acetylene gas** through **APL Industrial Gases** (Raigad). - Provides **engineering services** (APL Engineering Services): design/fabrication of **heat exchangers, pressure vessels, boilers** (100 MT/month capacity). --- ### **Manufacturing & Infrastructure** - **Two integrated facilities** spanning ~43–56 acres in **Turbhe (Navi Mumbai)** and **Raigad, Maharashtra**. - **Total installed capacity**: **32,760 metric tonnes per annum (MTPA)** for specialty amines. - **Turbhe Plant**: - 18.11-acre site, 30 km from Mumbai, with port proximity. - Produces ethanolamines, morpholine derivatives, MDEA, EO/PO products. - Achieved **85% capacity utilization in FY25**. - Houses **in-house R&D center** and a team of **252 personnel**. - Modular expansion potential due to underutilized land. - Advanced infrastructure with **continuous-reaction systems**, **multipurpose process lines**, and **zero-liquid discharge (ZLD)** facilities. --- ### **Strategic Strengths & Competitive Advantages** - **Technology Leadership**: - Pioneered **indigenous MDEA and NMMO production** in India. - Owns **proprietary processes** in ethoxylation, cyclization, morpholine synthesis, and dehydration. - **High Entry Barriers**: - Complex multi-step reactions, strict regulatory compliance (ISO 9001, 14001, 45001), and **lengthy customer validation cycles** (especially in pharma & refineries). - Robust **safety protocols** for handling hazardous materials (EO, PO, alkanolamines). - **Global Diversification**: - Exports to **85+ countries**, reducing region-specific demand volatility. - Subsidiary **Amines & Plasticizers FZ LLC** in **UAE** enables regional market expansion. - **Promoter-Led, Self-Funded Growth**: - Managed by **Mr. Hemant Kumar Ruia**, a first-generation entrepreneur with 40+ years of leadership. - Maintains a **prudent financial posture**, with growth funded through internal accruals. - **Conservative credit policy**: strict domestic credit control; exports on advance/LC basis. --- ### **R&D & Innovation** APL’s in-house R&D is a cornerstone of its growth and differentiation: - **DSIR-recognized Centre of Excellence**. - **25+ technical professionals**, including doctorates and industry experts. - **Key R&D Achievements (Last 5 Years)**: - Commercialized **43 new products**. - Developed **12+ custom solvent formulations** and **25+ tailored solutions** for domestic & global clients. - Created **carbon capture formulations** and **demulsifiers** for country-specific crude and environmental standards. - **Focus Areas**: - **Import substitution**: For battery materials, hydrogen electrolyzers, semiconductor-grade chemicals. - **Green chemistry**: Fermentation-based amine synthesis, neem-based agrochemical emulsifiers, low-emission solvent production. - **Sustainability**: Completed **carbon footprint assessment** for all product lines; advancing green raw material routes for NMMO. - Partnerships with IITs and global MNCs for technology development. --- ### **Market Position & Customers** - **Dominant domestic player**: Holds **75–80% share** of India’s ethanolamines market. - **Major clients**: - All **public sector oil & petrochemical companies** in India. - Global **Fortune 500** firms in refining, agrochemicals, pharmaceuticals, and textiles. - Clients in **electronics chip manufacturing**, **automotive**, **construction**, and **coatings**. - Services **oil & gas, pharma, agrochemicals, textiles, personal care, energy, and infrastructure** — ensuring **diversified revenue streams**. --- ### **Sustainability & ESG Initiatives** - **Energy Security & Cost Efficiency**: - Holds **26% stake** in **Radiance MH Sunrise Six Pvt Ltd**, which operates a **dedicated grid-connected solar plant**. - Receives **concessional solar power**, reducing energy costs and carbon footprint. - **Environmental Stewardship**: - Implements **ZLD systems**, **effluent treatment**, and green chemistry practices. - Develops **eco-friendly alternatives** to polluting industrial processes (e.g., NMMO for viscose fiber). - **Decarbonization Efforts**: - MDEA and solvents play a **critical role in CO₂ capture** in grey, blue, and turquoise hydrogen production. - R&D focused on **carbon capture and utilization (CCU)** technologies. --- ### **Challenges** - **Raw Material Volatility**: Dependent on **ethylene oxide (EO)**, the price of which is linked to crude oil; in-house production not viable. - **Rising Costs**: Increasing energy, shipping freight, and piped natural gas (PNG) prices compress margins. - **Competition**: From both domestic and international specialty chemical players. ---